PALISADE BIO INC
For the period ended Mar 31, 2024. Filed May 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 13, 2024
PALI$1.19+5.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
ance Sheets (Unaudited)
(in thousands, except share and per share amounts)
| March 31, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $11,276 | $12,432 |
| Prepaid expenses and other current assets | 737 | 896 |
| Total current assets | 12,013 | 13,328 |
| Restricted cash | 26 | 26 |
| Property and equipment, net | 5 | 10 |
| Operating lease right-of-use asset | 170 | 198 |
| Other noncurrent assets | 438 | 490 |
| Total assets | $12,652 | $14,052 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $459 | $698 |
| Accrued liabilities | 1,670 | 831 |
| Accrued compensation and benefits | 213 | 778 |
| Current portion of operating lease liability | 125 | 121 |
| Insurance financing debt | — | 158 |
| Total current liabilities | 2,467 | 2,586 |
| Warrant liability | 2 | 2 |
| Contingent consideration obligation | 61 | 61 |
| Operating lease liability, net of current portion | 58 | 90 |
| Total liabilities | 2,588 | 2,739 |
| Commitments and contingencies (Note 8) | ||
| Stockholders' equity: | ||
| Series A Convertible Preferred Stock, $0.01 par value, 7,000,000 shares authorized; 200,000 issued and outstanding at March 31, 2024 and December 31, 2023 | 2 | 2 |
| Common stock, $0.01 par value; 280,000,000 shares authorized;851,302 and 618,056 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 8 | 6 |
| Additional paid-in capital | 135,087 | 132,811 |
| Accumulated deficit | (125,033) | (121,506) |
| Total stockholders' equity | 10,064 | 11,313 |
| Total liabilities and stockholders' equity | $12,652 | $14,052 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.